Telomere‐based DNA damage responses: a new approach to melanoma
- 1 July 2004
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 18 (12) , 1373-1381
- https://doi.org/10.1096/fj.04-1774com
Abstract
Melanoma is the most fatal skin cancer, often highly resistant to chemotherapy. Here we show that treatment with an 11-base DNA oligonucleotide homologous to the telomere 3′ overhang sequence (T-oligo) induces apoptosis of several established human melanoma cell lines, including the aggressive MM-AN line, whereas normal human melanocytes exposed to the same or higher T-oligo concentrations show only transient cell cycle arrest, implying that malignant cells are more sensitive to T-oligo effects. When MM-AN cells were briefly exposed to T-oligo in culture and injected into the flank or tail vein of SCID mice, eventual tumor volume and number of metastases were reduced 85–95% compared with control mice. Similarly, T-oligos administered intralesionally or systemically selectively inhibited the growth of previously established MM-AN tumor nodules in the flank and peritoneal cavity by 85 to 90% without detectable toxicity. We previously showed that T-oligos act through ATM, p95/Nbs1, E2F1, p16INK4A, p53, and the p53 homologue p73 to modulate downstream effectors and now additionally demonstrate striking down-regulation of the inhibitor of apoptosis protein livin/ML-IAP. We suggest that T-oligo mimics a physiologic DNA damage signal that is frequently masked in malignant cells and thereby activates innate cancer prevention responses. T-oligos may provide a novel therapeutic approach to melanoma.—Puri, N., Eller, M. S., Byers, H. R., Dykstra, S., Kubera, J., Gilchrest, B. A. Telomere-based DNA damage responses: a new approach to melanoma.Keywords
Funding Information
- American Skin Association
This publication has 49 references indexed in Scilit:
- Cancer Statistics, 2004CA: A Cancer Journal for Clinicians, 2004
- Induction of a p95/Nbs1‐mediated S phase checkpoint by telomere 3′ overhang specific DNAThe FASEB Journal, 2002
- Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor LymphocytesScience, 2002
- Induction of Apoptosis by Telomere 3′ Overhang-Specific DNAExperimental Cell Research, 2002
- Mutations of the BRAF gene in human cancerNature, 2002
- DNA oligonucleotide treatment corrects the age‐associated decline in DNA repair capacityThe FASEB Journal, 2002
- Tyrosinase Gene Expression is Regulated by p53Journal of Investigative Dermatology, 2002
- Telomerase Catalytic Subunit Homologs from Fission Yeast and HumanScience, 1997
- Specific Association of Human Telomerase Activity with Immortal Cells and CancerScience, 1994
- DNA damage and melanogenesisNature, 1994